TSBX

COM:TURNSTONEBIO

Turnstone Biologics

  • Stock

USD

Last Close

0.47

22/11 21:00

Market Cap

55.51M

Beta: -

Volume Today

151.38K

Avg: -

Description

Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous ...Show More

peer of

competitor of